According to Trendlines, Celleste Bio intends to transform the chocolate market by using AI modelling to tailor cocoa butter for specific melting points and flavour profiles, giving manufacturers a boost in innovation and competitiveness.
Meanwhile, Celleste Bio is developing a resilient supply chain by achieving commercial-scale cocoa butter production in a 1000-liter bioreactor using only a single cocoa bean.
Trendlines claims that this process eliminates the sole dependence on the traditional farming of cocoa trees and supplements production, without replacing it.
“This milestone demonstrates Celleste Bio's cell cultured ingredients are bio-identical to conventionally grown cocoa - meaning they deliver the same texture, melt profile and sensory experience, and sets the stage for scaling production to market-ready quantities in the foreseeable future,” says Haim Brosh, Trendlines’ CEO.
See also: MoneyMax taps pawnbroking and timeless gold to provide value across generations
Shares in Trendlines closed flat at 5.6 cents on April 21.
